Price T Rowe Associates Inc Ani Pharmaceuticals Inc Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 9,222 shares of ANIP stock, worth $821,956. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,222
Previous 8,089
14.01%
Holding current value
$821,956
Previous $542,000
11.07%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ANIP
# of Institutions
243Shares Held
20MCall Options Held
19.9KPut Options Held
12.8K-
Black Rock Inc. New York, NY2.66MShares$237 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$114 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$89.5 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$76.8 Million3.45% of portfolio
-
State Street Corp Boston, MA716KShares$63.8 Million0.0% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.55B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...